phenylbutazone has been researched along with Equine Diseases in 135 studies
Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.
Excerpt | Relevance | Reference |
---|---|---|
" Anecdotally, many practitioners prescribe omeprazole concurrently with phenylbutazone to reduce development of equine gastric ulcer syndrome (EGUS), but the efficacy and safety of this practice remains unknown." | 9.41 | Impact of concurrent treatment with omeprazole on phenylbutazone-induced equine gastric ulcer syndrome (EGUS). ( Andrews, FM; Banse, HE; Chapman, A; Garza, F; Keowen, M; Paul, L; Ricord, M; Yñiguez, FJM, 2021) |
"To assess the clinical, biochemical, and histologic effects of topically administered diclofenac liposomal cream (DLC) in the treatment of horses with experimentally induced osteoarthritis." | 9.14 | Evaluation of topically administered diclofenac liposomal cream for treatment of horses with experimentally induced osteoarthritis. ( Frisbie, DD; Kawcak, CE; McIlwraith, CW; Pearce, GL; Werpy, NM, 2009) |
"To compare efficacy and safety of paste formulations of firocoxib and phenylbutazone in horses with naturally occurring osteoarthritis." | 9.13 | Comparison of efficacy and safety of paste formulations of firocoxib and phenylbutazone in horses with naturally occurring osteoarthritis. ( Alva, R; Bertone, AL; Doucet, MY; Hanson, PD; Hendrickson, D; Hughes, F; Kunkle, B; Macallister, C; McClure, S; Reinemeyer, C; Romano, D; Rossier, Y; Sifferman, R; Vrins, AA; White, G, 2008) |
"The eicosanoids, prostaglandin E2 (PGE2) and leukotriene B4, increased in synovial fluid after synovitis induction in all horses then returned to near baseline by 48 hours." | 9.08 | Effects of pretreatment with ketoprofen and phenylbutazone on experimentally induced synovitis in horses. ( Kamerling, SG; Keowen, ML; Owens, JG; Prescott-Mathews, JS; Stanton, SR, 1996) |
"A 15-year-old Quarter Horse gelding and a 26-year-old Thoroughbred gelding were evaluated because of hematuria of 4 to 6 days' duration following prolonged oral administration of phenylbutazone." | 7.77 | Ulcerative cystitis associated with phenylbutazone administration in two horses. ( Aleman, M; Higgins, JK; Nieto, JE, 2011) |
"In horses with navicular syndrome treated once daily for 4 days, typical clinical doses of flunixin and phenylbutazone resulted in similar significant improvement in lameness at 6, 12, and 24 hours after the final dose, compared with findings in horses treated with saline solution." | 7.73 | Use of force plate analysis to compare the analgesic effects of intravenous administration of phenylbutazone and flunixin meglumine in horses with navicular syndrome. ( Clarke, CR; Erkert, RS; MacAllister, CG; Payton, ME, 2005) |
"Phenylbutazone (PBZ) toxicosis was induced in 9 ponies to further define the clinical and pathologic changes occurring with this syndrome." | 7.67 | Experimentally induced phenylbutazone toxicosis in ponies: description of the syndrome and its prevention with synthetic prostaglandin E2. ( Collins, LG; Tyler, DE, 1985) |
"Phenylbutazone has been shown to alter GI barrier function both in vitro and ex vivo, but its effects on barrier function have not been assessed in vivo." | 7.01 | Effects of phenylbutazone alone or in combination with a nutritional therapeutic on gastric ulcers, intestinal permeability, and fecal microbiota in horses. ( Bradbery, A; Chamoun-Emanuelli, AM; Cohen, ND; Coleman, MC; DeSolis, CN; Much, M; Sowinski, R; Tetrault, T; Whitfield-Cargile, CM, 2021) |
"Ketorolac tromethamine was not superior to FM or PB in reducing lameness using a HBS model." | 6.94 | Ketorolac Is Not More Effective Than Flunixin Meglumine or Phenylbutazone in Reducing Foot Pain in Horses. ( Brunner, TJ; Cooper, BR; Davern, AJ; Grady, SE; Lescun, TB; Moore, GE; Taylor, SD, 2020) |
"Although PBZ is clinically effective in treating acute synovitis, it does not limit inflammation-induced cartilage catabolism and may transiently reduce collagen anabolism as evidenced by SF markers." | 6.79 | In vivo effects of phenylbutazone on inflammation and cartilage-derived biomarkers in equine joints with acute synovitis. ( Brunott, A; de Grauw, JC; van de Lest, CH; van Loon, JP; van Weeren, PR, 2014) |
" The objectives of the current study were to describe blood and urine concentrations and the pharmacokinetics of PBZ and its metabolites following intravenous (IV) and oral administration and to describe the duration of pharmacodynamic effect." | 5.51 | Phenylbutazone blood and urine concentrations, pharmacokinetics, and effects on biomarkers of inflammation in horses following intravenous and oral administration of clinical doses. ( Arthur, RM; Hamamoto-Hardman, B; Kass, PH; Knych, HK; McKemie, DS; Seminoff, K, 2019) |
" Anecdotally, many practitioners prescribe omeprazole concurrently with phenylbutazone to reduce development of equine gastric ulcer syndrome (EGUS), but the efficacy and safety of this practice remains unknown." | 5.41 | Impact of concurrent treatment with omeprazole on phenylbutazone-induced equine gastric ulcer syndrome (EGUS). ( Andrews, FM; Banse, HE; Chapman, A; Garza, F; Keowen, M; Paul, L; Ricord, M; Yñiguez, FJM, 2021) |
" One group received a high dose of PBZ for two weeks; the second group was given an equimolecular dosage of SBZ; and a third group received placebo." | 5.32 | Lower gastric ulcerogenic effect of suxibuzone compared to phenylbutazone when administered orally to horses. ( Homedes, J; Mayós, I; Monreal, L; Sabaté, D; Segura, D, 2004) |
"Hoof pain was quantified objectively by means of an electronic hoof tester and lameness was subjectively graded on a modified Obel scale." | 5.29 | Effects of ketoprofen and phenylbutazone on chronic hoof pain and lameness in the horse. ( Kamerling, SG; Keowen, ML; Owens, JG; Stanton, SR, 1995) |
"Phenylbutazone was cleared more slowly from exudate than from plasma." | 5.27 | Effects of a phenylbutazone paste in ponies: model of acute nonimmune inflammation. ( Higgins, AJ; Lees, P, 1986) |
"To assess the clinical, biochemical, and histologic effects of topically administered diclofenac liposomal cream (DLC) in the treatment of horses with experimentally induced osteoarthritis." | 5.14 | Evaluation of topically administered diclofenac liposomal cream for treatment of horses with experimentally induced osteoarthritis. ( Frisbie, DD; Kawcak, CE; McIlwraith, CW; Pearce, GL; Werpy, NM, 2009) |
"To compare efficacy and safety of paste formulations of firocoxib and phenylbutazone in horses with naturally occurring osteoarthritis." | 5.13 | Comparison of efficacy and safety of paste formulations of firocoxib and phenylbutazone in horses with naturally occurring osteoarthritis. ( Alva, R; Bertone, AL; Doucet, MY; Hanson, PD; Hendrickson, D; Hughes, F; Kunkle, B; Macallister, C; McClure, S; Reinemeyer, C; Romano, D; Rossier, Y; Sifferman, R; Vrins, AA; White, G, 2008) |
"The eicosanoids, prostaglandin E2 (PGE2) and leukotriene B4, increased in synovial fluid after synovitis induction in all horses then returned to near baseline by 48 hours." | 5.08 | Effects of pretreatment with ketoprofen and phenylbutazone on experimentally induced synovitis in horses. ( Kamerling, SG; Keowen, ML; Owens, JG; Prescott-Mathews, JS; Stanton, SR, 1996) |
"Although both classes of NSAID induced gastric ulceration, the COX-2 selective NSAID firocoxib induced less severe glandular ulceration." | 3.88 | Effect of selective versus nonselective cyclooxygenase inhibitors on gastric ulceration scores and intestinal inflammation in horses. ( Chamoun-Emanuelli, AM; Cohen, ND; Dockery, HJ; Richardson, LM; Whitfield-Cargile, CM, 2018) |
"A 15-year-old Quarter Horse gelding and a 26-year-old Thoroughbred gelding were evaluated because of hematuria of 4 to 6 days' duration following prolonged oral administration of phenylbutazone." | 3.77 | Ulcerative cystitis associated with phenylbutazone administration in two horses. ( Aleman, M; Higgins, JK; Nieto, JE, 2011) |
"Using an adjustable heart bar shoe model of foot pain, the objective of this study was to test the hypothesis that the combined use of phenylbutazone (PBZ) and flunixin meglumine (FM) would prove more efficacious in alleviating lameness than either drug alone." | 3.77 | Phenylbutazone and flunixin meglumine used singly or in combination in experimental lameness in horses. ( Foreman, JH; Ruemmler, R, 2011) |
"In horses with navicular syndrome treated once daily for 4 days, typical clinical doses of flunixin and phenylbutazone resulted in similar significant improvement in lameness at 6, 12, and 24 hours after the final dose, compared with findings in horses treated with saline solution." | 3.73 | Use of force plate analysis to compare the analgesic effects of intravenous administration of phenylbutazone and flunixin meglumine in horses with navicular syndrome. ( Clarke, CR; Erkert, RS; MacAllister, CG; Payton, ME, 2005) |
"In these Thoroughbreds, phenylbutazone treatment did not modify heart rate or right atrial and pulmonary vascular pressures at rest or during exercise capable of eliciting exercise-induced pulmonary hemorrhage." | 3.69 | Pulmonary vascular pressures of strenuously exercising thoroughbreds after administration of phenylbutazone. ( Goetz, TE; Griffin, R; Manohar, M; Sullivan, E, 1996) |
"Phenylbutazone (PBZ) toxicosis was induced in 9 ponies to further define the clinical and pathologic changes occurring with this syndrome." | 3.67 | Experimentally induced phenylbutazone toxicosis in ponies: description of the syndrome and its prevention with synthetic prostaglandin E2. ( Collins, LG; Tyler, DE, 1985) |
"During 1975 and 1976, 70 Standardbred horses with cunean bursitis-tarsitis were treated by cunean tenectomy or by more conservative approaches (rested, given corticosteroid injections in the cunean bursa and distal hock articulations, given an oral course of phenylbutazone, a combination of these) or were sold." | 3.66 | Treatment and prognosis for cunean tendon bursitis-tarsitis of Standardbred horses. ( Gabel, AA, 1979) |
"Phenylbutazone has been shown to alter GI barrier function both in vitro and ex vivo, but its effects on barrier function have not been assessed in vivo." | 3.01 | Effects of phenylbutazone alone or in combination with a nutritional therapeutic on gastric ulcers, intestinal permeability, and fecal microbiota in horses. ( Bradbery, A; Chamoun-Emanuelli, AM; Cohen, ND; Coleman, MC; DeSolis, CN; Much, M; Sowinski, R; Tetrault, T; Whitfield-Cargile, CM, 2021) |
"Ketorolac tromethamine was not superior to FM or PB in reducing lameness using a HBS model." | 2.94 | Ketorolac Is Not More Effective Than Flunixin Meglumine or Phenylbutazone in Reducing Foot Pain in Horses. ( Brunner, TJ; Cooper, BR; Davern, AJ; Grady, SE; Lescun, TB; Moore, GE; Taylor, SD, 2020) |
"Although PBZ is clinically effective in treating acute synovitis, it does not limit inflammation-induced cartilage catabolism and may transiently reduce collagen anabolism as evidenced by SF markers." | 2.79 | In vivo effects of phenylbutazone on inflammation and cartilage-derived biomarkers in equine joints with acute synovitis. ( Brunott, A; de Grauw, JC; van de Lest, CH; van Loon, JP; van Weeren, PR, 2014) |
"Phenylbutazone paste was administered at approximately 2." | 2.73 | Effectiveness of administration of phenylbutazone alone or concurrent administration of phenylbutazone and flunixin meglumine to alleviate lameness in horses. ( Keegan, KG; Kramer, J; Messer, NT; Reed, SK; Wilson, DA, 2008) |
"To compare analgesic effects of phenylbutazone administered at a dosage of 4." | 2.71 | Evaluation of the analgesic effects of phenylbutazone administered at a high or low dosage in horses with chronic lameness. ( Erkert, RS; Hu, HH; MacAllister, CG; Payton, ME, 2005) |
"Phenylbutazone was administered as before, and PVGRF was measured." | 2.71 | Quantitative comparison of three commonly used treatments for navicular syndrome in horses. ( Blaik, MA; Jann, HW; Schoonover, MJ, 2005) |
" The plasma kinetics of phenylbutazone may be dose dependent, with the plasma half-life increasing as the drug dosage level increases." | 2.37 | Phenylbutazone in the horse: a review. ( Blake, JW; Chay, S; Kamerling, S; Lees, P; Tobin, T; Weckman, TJ; Woods, WE, 1986) |
"Arachidonic acid is a polyunsaturated fatty acid covalently bound in esterified form in the cell membranes of most body cells." | 2.37 | The acute inflammatory process, arachidonic acid metabolism and the mode of action of anti-inflammatory drugs. ( Higgins, AJ; Lees, P, 1984) |
" The objectives of the current study were to describe blood and urine concentrations and the pharmacokinetics of PBZ and its metabolites following intravenous (IV) and oral administration and to describe the duration of pharmacodynamic effect." | 1.51 | Phenylbutazone blood and urine concentrations, pharmacokinetics, and effects on biomarkers of inflammation in horses following intravenous and oral administration of clinical doses. ( Arthur, RM; Hamamoto-Hardman, B; Kass, PH; Knych, HK; McKemie, DS; Seminoff, K, 2019) |
" The goal of this study was to determine the safety of a 10-day dosage regimen of phenylbutazone and firocoxib, both at their standard dosages, in horses." | 1.40 | Evaluation of the safety of a combination of oral administration of phenylbutazone and firocoxib in horses. ( Kivett, L; Taintor, J; Wright, J, 2014) |
" Veterinarians should monitor serum albumin concentrations and neutrophil counts and be cautious when making dosing recommendations for phenylbutazone treatment of horses." | 1.35 | Pathophysiologic effects of phenylbutazone on the right dorsal colon in horses. ( Hubert, JD; McConnico, RS; Moore, RM; Morgan, TW; Williams, CC, 2008) |
" One group received a high dose of PBZ for two weeks; the second group was given an equimolecular dosage of SBZ; and a third group received placebo." | 1.32 | Lower gastric ulcerogenic effect of suxibuzone compared to phenylbutazone when administered orally to horses. ( Homedes, J; Mayós, I; Monreal, L; Sabaté, D; Segura, D, 2004) |
"Pulmonary granular cell tumor is a locally invasive but rare type of tumor with low metastatic potential." | 1.31 | Treatment of granular cell tumor via complete right lung resection in a horse. ( Adams, SB; Chilcoat, CD; Dutweiler, VA; Facemire, PR; Irizarry, AR; Morisset, SS; Sojka, JE; Weirich, WE, 2000) |
"The therapy was repeated following recurrence of the lameness." | 1.30 | [Navicular disease in the hind limb of a Warmblood horse]. ( Meijer, MC; Rijkenhuizen, AB, 1999) |
" Pharmacokinetic variables calculated for each drug when given alone and in combination were similar to those reported." | 1.29 | Effects of concurrent administration of phenylbutazone and flunixin meglumine on pharmacokinetic variables and in vitro generation of thromboxane B2 in mares. ( Ashcraft, SM; Harris, ON; Sams, RA; Semrad, SD, 1993) |
"Phenylbutazone-treated horses had a significant (P < 0." | 1.29 | Comparison of adverse effects of phenylbutazone, flunixin meglumine, and ketoprofen in horses. ( Borne, AT; MacAllister, CG; Morgan, SJ; Pollet, RA, 1993) |
"Hoof pain was quantified objectively by means of an electronic hoof tester and lameness was subjectively graded on a modified Obel scale." | 1.29 | Effects of ketoprofen and phenylbutazone on chronic hoof pain and lameness in the horse. ( Kamerling, SG; Keowen, ML; Owens, JG; Stanton, SR, 1995) |
"Phenylbutazone was more effective than flunixin and this was significant (P < 0." | 1.28 | Antagonism of endotoxin-induced disruption of equine bowel motility by flunixin and phenylbutazone. ( Gerring, EL; King, JN, 1989) |
"oral phenylbutazone treatment over the next 3 years allowed the stallion to continue its show career." | 1.28 | Arthroscopic removal of a palmar radial osteochondroma causing carpal canal syndrome in a horse. ( Adams, SB; Coatney, RW; Habig, C; Squire, KR; Widmer, WR, 1992) |
"Phenylbutazone is a potent nonsteroidal, anti-inflammatory drug often used by veterinarians to treat racetrack animals." | 1.28 | Poisoning with equine phenylbutazone in a racetrack worker. ( Newton, TA; Rose, SR, 1991) |
" Phenylbutazone was administered at a dosage of 10 mg/kg of bodyweight (BW) per day, intravenously (IV), in equally divided doses to three of the groups." | 1.28 | The protective effects of sucralfate and ranitidine in foals experimentally intoxicated with phenylbutazone. ( Geor, RJ; Papich, MG; Petrie, L; Rousseaux, C, 1989) |
" A decrease in total blood neutrophil count occurred in all horses, and was associated with toxic left shift in horses given the 2 larger dosage schedules." | 1.27 | Effects of large doses of phenylbutazone administration to horses. ( French, TW; MacKay, RJ; Mayhew, IG; Nguyen, HT, 1983) |
"Five pairs of matched horses were used to study the biochemical and haematological effects of a revised dosage schedule of phenylbutazone." | 1.27 | Biochemical and haematological effects of a revised dosage schedule of phenylbutazone in horses. ( Gerring, EL; Lees, P; Maitho, TE; Millar, JD; Taylor, JB; Walland, A, 1983) |
"This case was unusual because septicemia with salmonellosis is an uncommon finding in adult equids." | 1.27 | Septicemic salmonellosis and suspected phenylbutazone toxicosis in an aged pony. ( Hondalus, MK; Lofstedt, J, 1988) |
"Phenylbutazone was cleared more slowly from exudate than from plasma." | 1.27 | Effects of a phenylbutazone paste in ponies: model of acute nonimmune inflammation. ( Higgins, AJ; Lees, P, 1986) |
" The results suggested that at a similar dose rate of 5 mg/kg greater bioavailability results from the paste than from a powder preparation." | 1.27 | Studies on a new paste preparation of phenylbutazone. ( Douglas, TA; Snow, DH, 1983) |
"Phenylbutazone (PBZ) is a nonsteroidal antiinflammatory drug (NSAID) that is not commonly prescribed due to the high incidence of serious adverse reactions." | 1.27 | Horse pill ("bute") hemorrhage. ( Cohen, ML; Davis, M; Gogel, HK; Ming, RH; Pitcher, JL, 1988) |
" Considerable individual variation was observed both in timing and magnitude of the plasma drug responses between horses, but 24 h after dosing a clear dose response relation was recorded." | 1.26 | Pharmacokinetics of phenylbutazone and its metabolites in the horse. ( Gerring, EL; Lees, P; Taylor, JB, 1981) |
" At dosage levels of 10 to 12 mg/kg of body weight/day for 8 to 10 days, ponies frequently developed clinical signs of toxicosis characterized by hypoproteinemia." | 1.26 | Phenylbutazone toxicosis in equidae: a biochemical and pathophysiological study. ( Douglas, TA; Holmes, PH; Parkins, JJ; Snow, DH; Thompson, H, 1981) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 51 (37.78) | 18.7374 |
1990's | 28 (20.74) | 18.2507 |
2000's | 33 (24.44) | 29.6817 |
2010's | 18 (13.33) | 24.3611 |
2020's | 5 (3.70) | 2.80 |
Authors | Studies |
---|---|
Meinke, PT | 1 |
Ahmadnejad, M | 1 |
Jalilzadeh-Amin, G | 1 |
Sykes, BW | 1 |
Ricord, M | 1 |
Andrews, FM | 2 |
Yñiguez, FJM | 1 |
Keowen, M | 1 |
Garza, F | 1 |
Paul, L | 1 |
Chapman, A | 1 |
Banse, HE | 2 |
Grady, SE | 1 |
Lescun, TB | 1 |
Moore, GE | 1 |
Cooper, BR | 1 |
Davern, AJ | 1 |
Brunner, TJ | 1 |
Taylor, SD | 1 |
Whitfield-Cargile, CM | 2 |
Coleman, MC | 1 |
Cohen, ND | 2 |
Chamoun-Emanuelli, AM | 2 |
DeSolis, CN | 1 |
Tetrault, T | 1 |
Sowinski, R | 1 |
Bradbery, A | 1 |
Much, M | 1 |
van Galen, G | 1 |
Saegerman, C | 1 |
Hyldahl Laursen, S | 1 |
Jacobsen, S | 1 |
Andersson Munk, M | 1 |
Sjöström, H | 1 |
Holm Lindmark, S | 1 |
Verwilghen, D | 1 |
Pedersen, SK | 1 |
Cribb, AE | 1 |
Read, EK | 1 |
French, D | 1 |
Richardson, LM | 1 |
Dockery, HJ | 1 |
Knych, HK | 1 |
Arthur, RM | 1 |
McKemie, DS | 1 |
Seminoff, K | 1 |
Hamamoto-Hardman, B | 1 |
Kass, PH | 1 |
Tesena, P | 1 |
Yingchutrakul, Y | 1 |
Roytrakul, S | 1 |
Wongtawan, T | 1 |
Angkanaporn, K | 1 |
Dabareiner, RM | 1 |
Chaffin, MK | 1 |
Quirham, H | 1 |
Carter, GK | 2 |
Sandmeyer, LS | 1 |
Bauer, BS | 1 |
Grahn, BH | 1 |
Kivett, L | 1 |
Taintor, J | 1 |
Wright, J | 1 |
de Grauw, JC | 2 |
van Loon, JP | 2 |
van de Lest, CH | 1 |
Brunott, A | 2 |
van Weeren, PR | 2 |
Martínez Aranzales, JR | 1 |
Cândido de Andrade, BS | 1 |
Silveira Alves, GE | 1 |
Fodey, TL | 1 |
Smyth, WG | 1 |
Barnes, P | 1 |
Traynor, IM | 1 |
Kennedy, DG | 1 |
Crooks, SR | 1 |
Bonilla, AG | 1 |
Santschi, EM | 1 |
Longhofer, SL | 2 |
Reinemeyer, CR | 2 |
Radecki, SV | 1 |
Cohausz, O | 1 |
Müntener, CR | 1 |
Trachsel, D | 1 |
Wimmershoff, J | 1 |
Eser, MW | 1 |
McConnico, RS | 1 |
Morgan, TW | 1 |
Williams, CC | 1 |
Hubert, JD | 1 |
Moore, RM | 1 |
Frisbie, DD | 1 |
McIlwraith, CW | 2 |
Kawcak, CE | 1 |
Werpy, NM | 1 |
Pearce, GL | 1 |
Sabaté, D | 2 |
Homedes, J | 2 |
Salichs, M | 1 |
Sust, M | 1 |
Monreal, L | 2 |
Foreman, JH | 2 |
Grubb, TL | 1 |
Inoue, OJ | 1 |
Banner, SE | 1 |
Ball, KT | 1 |
Soma, LR | 2 |
Uboh, CE | 1 |
Maylin, GM | 1 |
Aleman, M | 1 |
Nieto, JE | 1 |
Higgins, JK | 1 |
Ruemmler, R | 1 |
Clark-Price, SC | 1 |
Gutierrez-Nibeyro, SD | 1 |
Santos, MP | 1 |
Weerts, EA | 1 |
Stein, C | 1 |
Jones, SL | 1 |
Davis, J | 1 |
Rowlingson, K | 1 |
Segura, D | 1 |
Mayós, I | 1 |
Morton, AJ | 1 |
Campbell, NB | 1 |
Gayle, JM | 1 |
Redding, WR | 1 |
Blikslager, AT | 1 |
Hu, HH | 1 |
MacAllister, CG | 4 |
Payton, ME | 2 |
Erkert, RS | 2 |
Clarke, CR | 1 |
Hewes, CA | 1 |
Schneider, RK | 1 |
Baszler, TV | 1 |
Oaks, JL | 1 |
Xie, H | 1 |
Colahan, P | 1 |
Ott, EA | 1 |
Schoonover, MJ | 1 |
Jann, HW | 1 |
Blaik, MA | 1 |
Groves, L | 1 |
Reed, SK | 2 |
Messer, NT | 2 |
Tessman, RK | 1 |
Keegan, KG | 2 |
Mogg, TD | 2 |
Rutherford, DJ | 1 |
Stewart, AJ | 1 |
Hart, J | 1 |
Wearn, J | 1 |
Katz, L | 1 |
Sullivan, KA | 1 |
Hill, AE | 1 |
Haussler, KK | 1 |
Doucet, MY | 1 |
Bertone, AL | 3 |
Hendrickson, D | 1 |
Hughes, F | 1 |
Macallister, C | 1 |
McClure, S | 1 |
Reinemeyer, C | 1 |
Rossier, Y | 1 |
Sifferman, R | 1 |
Vrins, AA | 1 |
White, G | 1 |
Kunkle, B | 1 |
Alva, R | 1 |
Romano, D | 1 |
Hanson, PD | 1 |
Boissevain, I | 1 |
Wilson, DA | 1 |
Kramer, J | 1 |
de Grauw, J | 1 |
Lipman, LJ | 1 |
Vogel, C | 1 |
Higgins, AJ | 3 |
Lees, P | 10 |
Faulkner, LW | 1 |
Erb, HN | 2 |
King, JM | 2 |
Taylor, JB | 5 |
Gunson, DE | 2 |
Verrall, JH | 2 |
Snow, DH | 6 |
Chandler, N | 1 |
Jones, RD | 1 |
Parker, J | 1 |
Traub, JL | 1 |
Gallina, AM | 1 |
Grant, BD | 1 |
Reed, SM | 1 |
Gavin, PR | 1 |
Paulsen, LM | 1 |
Power, HT | 1 |
Watrous, BJ | 1 |
de Lahunta, A | 1 |
Read, WK | 1 |
Gerring, EL | 4 |
Collins, LG | 2 |
Tyler, DE | 2 |
Meschter, CL | 2 |
Maylin, GA | 1 |
Krook, L | 2 |
Burrows, GE | 1 |
MacKay, RJ | 1 |
French, TW | 1 |
Nguyen, HT | 1 |
Mayhew, IG | 2 |
Walland, A | 1 |
Maitho, TE | 1 |
Millar, JD | 1 |
Douglas, TA | 4 |
Miller, RM | 1 |
Dresher, LK | 1 |
Hodgson, DR | 1 |
Jacobs, KA | 1 |
Thompson, H | 3 |
Parkins, JJ | 2 |
Holmes, PH | 2 |
Snow, D | 1 |
White, NA | 2 |
Johnson, CB | 1 |
Taylor, PM | 1 |
Young, SS | 1 |
Brearley, JC | 1 |
Semrad, SD | 1 |
Sams, RA | 1 |
Harris, ON | 1 |
Ashcraft, SM | 1 |
Morgan, SJ | 1 |
Borne, AT | 1 |
Pollet, RA | 1 |
Perrin, J | 1 |
Cosmetatos, I | 1 |
Gallusser, A | 1 |
Lobsiger, L | 1 |
Straub, R | 1 |
Nicolet, J | 1 |
Owens, JG | 2 |
Kamerling, SG | 2 |
Stanton, SR | 2 |
Keowen, ML | 2 |
Vatistas, NJ | 1 |
Pascoe, JR | 1 |
Wright, IM | 1 |
Dyson, SJ | 1 |
Slater, MR | 1 |
Hood, DM | 1 |
Prescott-Mathews, JS | 1 |
Manohar, M | 1 |
Goetz, TE | 1 |
Griffin, R | 1 |
Sullivan, E | 1 |
May, SA | 1 |
Hooke, RE | 1 |
Brusie, RW | 1 |
Sullins, KE | 1 |
Coffin, PC | 1 |
Parker, GA | 1 |
Anver, MR | 1 |
Rosenberger, JL | 1 |
King, JN | 1 |
Colbourne, CM | 1 |
Raidal, SL | 1 |
Yovich, JV | 2 |
Howell, JM | 1 |
Richardson, JL | 1 |
Warmerdam, EP | 1 |
Klein, WR | 1 |
van Herpen, BP | 1 |
Rijkenhuizen, AB | 2 |
van Swieten, HA | 1 |
Sertich, PL | 1 |
Pozor, MA | 1 |
Meyers, SA | 1 |
Brown, JS | 1 |
Ramirez, S | 1 |
Seahorn, TL | 1 |
Williams, J | 1 |
Ritmeester, AM | 1 |
Blevins, WE | 1 |
Ferguson, DW | 1 |
Adams, SB | 3 |
Van Harreveld, PD | 1 |
Gaughan, EM | 2 |
Meijer, MC | 1 |
Hough, ME | 1 |
Steel, CM | 1 |
Bolton, JR | 1 |
Rohde, C | 1 |
Anderson, DE | 1 |
Weisbrode, SE | 1 |
Trumble, TN | 1 |
Ingle-Fehr, J | 1 |
Hendrickson, DA | 1 |
Reilly, FK | 1 |
Adair, HS | 1 |
Goble, DO | 1 |
Schmidhammer, JL | 1 |
Shires, GM | 1 |
Facemire, PR | 1 |
Chilcoat, CD | 1 |
Sojka, JE | 2 |
Irizarry, AR | 1 |
Weirich, WE | 1 |
Morisset, SS | 1 |
Dutweiler, VA | 1 |
Hawkins, JF | 1 |
Frank, N | 1 |
Levy, M | 1 |
Hand, DR | 1 |
Watkins, JP | 1 |
Honnas, CM | 1 |
Kemper, D | 1 |
Jeffcott, LB | 1 |
Colles, CM | 1 |
Chand, N | 1 |
Eyre, P | 1 |
Gabel, AA | 1 |
Michell, AR | 1 |
Bogan, JA | 1 |
Ackerman, N | 1 |
Johnson, JH | 1 |
Dorn, CR | 1 |
Squire, KR | 1 |
Widmer, WR | 1 |
Coatney, RW | 1 |
Habig, C | 1 |
Auer, DE | 2 |
Ng, JC | 2 |
Reilly, JS | 1 |
Seawright, AA | 2 |
Newton, TA | 1 |
Rose, SR | 1 |
Tulleners, EP | 1 |
Simmons, TR | 1 |
Ducharme, NG | 1 |
Dill, SG | 1 |
Anderson, WI | 1 |
Ellison, RS | 1 |
Jacobs, RM | 1 |
Gilbert, M | 1 |
Maylin, G | 1 |
Corradino, R | 1 |
Geor, RJ | 1 |
Petrie, L | 1 |
Papich, MG | 1 |
Rousseaux, C | 1 |
Cohen, ML | 1 |
Ming, RH | 1 |
Gogel, HK | 1 |
Davis, M | 1 |
Pitcher, JL | 1 |
Hondalus, MK | 1 |
Lofstedt, J | 1 |
Tobin, T | 1 |
Chay, S | 1 |
Kamerling, S | 1 |
Woods, WE | 1 |
Weckman, TJ | 1 |
Blake, JW | 1 |
Neaderland, MH | 1 |
Riis, RC | 1 |
Rebhun, WC | 1 |
Jones, RL | 1 |
Norrdin, RW | 1 |
Radin, MJ | 1 |
Lebel, JL | 1 |
van Miert, AS | 1 |
Hunt, JM | 1 |
Edwards, GB | 1 |
Hopes, R | 1 |
Coffman, JR | 1 |
Garner, HE | 1 |
Dunn, PS | 1 |
Moss, MS | 1 |
Steck, W | 1 |
7 reviews available for phenylbutazone and Equine Diseases
Article | Year |
---|---|
Perspectives in animal health: old targets and new opportunities.
Topics: Animals; Anthelmintics; Anti-Inflammatory Agents, Non-Steroidal; Anti-Obesity Agents; Anti-Ulcer Age | 2001 |
The use of phenylbutazone in the horse.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Horse Diseases; Horses; Legislation, Drug; Phenylb | 2012 |
The acute inflammatory process, arachidonic acid metabolism and the mode of action of anti-inflammatory drugs.
Topics: Adrenal Cortex Hormones; Animals; Anti-Inflammatory Agents; Arachidonic Acid; Arachidonic Acids; Blo | 1984 |
Phenylbutazone and the horse--a review.
Topics: Agranulocytosis; Anemia; Animals; Cat Diseases; Cats; Dog Diseases; Dogs; Horse Diseases; Horses; Hu | 1977 |
Nonsteroidal anti-inflammatory drugs: a review. New applications in hypersensitivity reactions of cattle and horses.
Topics: Anaphylaxis; Animals; Anti-Inflammatory Agents; Arthritis; Ascariasis; Aspirin; Cattle; Cattle Disea | 1977 |
Phenylbutazone in the horse: a review.
Topics: Animals; Biological Availability; Blood Proteins; Horse Diseases; Horses; Kinetics; Pain; Phenylbuta | 1986 |
Acute laminitis.
Topics: Acute Disease; Adrenal Cortex Hormones; Animals; Anti-Bacterial Agents; Cathartics; Cystine; Hoof an | 1972 |
21 trials available for phenylbutazone and Equine Diseases
Article | Year |
---|---|
Prophylactic effects of Glycyrrhiza glabra root extract on phenylbutazone-induced Equine Glandular Gastric Disease (EGGD).
Topics: Animals; Antioxidants; Glycyrrhiza; Horse Diseases; Horses; Phenylbutazone; Stomach Diseases | 2022 |
Impact of concurrent treatment with omeprazole on phenylbutazone-induced equine gastric ulcer syndrome (EGUS).
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Horse Diseases; Horses; Omeprazole; Phenylbutazone | 2021 |
Ketorolac Is Not More Effective Than Flunixin Meglumine or Phenylbutazone in Reducing Foot Pain in Horses.
Topics: Animals; Clonixin; Cross-Over Studies; Horse Diseases; Horses; Ketorolac; Lameness, Animal; Pain; Ph | 2020 |
Effects of phenylbutazone alone or in combination with a nutritional therapeutic on gastric ulcers, intestinal permeability, and fecal microbiota in horses.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Horse Diseases; Horses; Microbiota; Permeability; | 2021 |
Phenylbutazone induces equine glandular gastric disease without decreasing prostaglandin E
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Dinoprostone; Enzyme-Linked Immunosorbent Assay; G | 2018 |
In vivo effects of phenylbutazone on inflammation and cartilage-derived biomarkers in equine joints with acute synovitis.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Collagen Type II | 2014 |
Evaluation of the palatability of three nonsteroidal antiinflammatory top-dress formulations in horses.
Topics: Administration, Oral; Animal Feed; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Stud | 2008 |
Evaluation of topically administered diclofenac liposomal cream for treatment of horses with experimentally induced osteoarthritis.
Topics: Administration, Topical; Animals; Arthrography; Cartilage, Articular; Diclofenac; Histocytochemistry | 2009 |
Multicentre, controlled, randomised and blinded field study comparing efficacy of suxibuzone and phenylbutazone in lame horses.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Female; Horse Diseases; Horse | 2009 |
Effects of top-dress formulations of suxibuzone and phenylbutazone on development of gastric ulcers in horses.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; F | 2009 |
Efficacy of single-dose intravenous phenylbutazone and flunixin meglumine before, during and after exercise in an experimental reversible model of foot lameness in horses.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Clonixin; Drug Administration Schedule; Female; Ho | 2010 |
Upregulation of articular synovial membrane μ-opioid-like receptors in an acute equine synovitis model.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthroscopy; Blotting, Western; Carpal Joints; Cro | 2013 |
Evaluation of the analgesic effects of phenylbutazone administered at a high or low dosage in horses with chronic lameness.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Dose-Response Relationship, Dr | 2005 |
Quantitative comparison of three commonly used treatments for navicular syndrome in horses.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomechanical Phenomena; Combined Modality Therapy | 2005 |
Effects of phenylbutazone alone or in combination with flunixin meglumine on blood protein concentrations in horses.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Proteins; Clonixin; Drug Therapy, Combinatio | 2006 |
The effects of chiropractic, massage and phenylbutazone on spinal mechanical nociceptive thresholds in horses without clinical signs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Back Pain; Biomechanical Phenomena; Combined Modal | 2008 |
Comparison of efficacy and safety of paste formulations of firocoxib and phenylbutazone in horses with naturally occurring osteoarthritis.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Female; Horse Diseases; Horses; L | 2008 |
Effectiveness of administration of phenylbutazone alone or concurrent administration of phenylbutazone and flunixin meglumine to alleviate lameness in horses.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Clonixin; Cross-Over Studies; Drug Therapy, Combin | 2008 |
Postoperative analgesia using phenylbutazone, flunixin or carprofen in horses.
Topics: Analgesia; Anesthesia; Animals; Anti-Inflammatory Agents, Non-Steroidal; Butorphanol; Carbazoles; Cl | 1993 |
Effects of pretreatment with ketoprofen and phenylbutazone on experimentally induced synovitis in horses.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dinoprostone; Disease Models, Anima | 1996 |
Digital perfusion, evaluated scintigraphically, and hoof wall growth in horses with chronic laminitis treated with egg bar-heart bar shoeing and coronary grooving.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Female; Foot Diseases; Hoof and C | 1998 |
107 other studies available for phenylbutazone and Equine Diseases
Article | Year |
---|---|
Colonic Health in Hospitalized Horses Treated with Non-Steroidal Anti-Inflammatory Drugs - A Preliminary Study.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colon; Horse Diseases; Horses; Pharmaceutical Prep | 2021 |
Effect of selective versus nonselective cyclooxygenase inhibitors on gastric ulceration scores and intestinal inflammation in horses.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2 Inhibitors; Fece | 2018 |
Phenylbutazone blood and urine concentrations, pharmacokinetics, and effects on biomarkers of inflammation in horses following intravenous and oral administration of clinical doses.
Topics: Administration, Intravenous; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; | 2019 |
Serum protein expression in Equine Glandular Gastric Disease (EGGD) induced by phenylbutazone.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Proteins; Horse Diseases; Horses; Male; Phen | 2019 |
Enthesopathy and desmitis of the medial collateral ligament of the cubital joint in 4 horses.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Female; Forelimb; Horse Diseases; Horses; Lameness | 2013 |
Diagnostic ophthalmology. Anterior uveitis of the right eye.
Topics: Animals; Atropine; Female; Horse Diseases; Horses; Phenylbutazone; Prednisolone; Uveitis, Anterior | 2013 |
Evaluation of the safety of a combination of oral administration of phenylbutazone and firocoxib in horses.
Topics: 4-Butyrolactone; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Prote | 2014 |
Orally administered phenylbutazone causes oxidative stress in the equine gastric mucosa.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Catalase; Dinoprostone; Fema | 2015 |
Investigation into sources of contamination of cattle with phenylbutazone.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cattle; Drug Residues; Feeding Methods; Food Conta | 2015 |
Comminuted fracture of the accessory carpal bone removed via an arthroscopic-assisted arthrotomy.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthroscopy; Carpal Bones; | 2015 |
[Drug interactions of phenylbutazone and phenprocoumon in a warmblood gelding].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Blood Coagulation Disorders; Drug | 2008 |
Pathophysiologic effects of phenylbutazone on the right dorsal colon in horses.
Topics: Animals; Colitis; Colon; Cross-Over Studies; Fatty Acids; Horse Diseases; Horses; Malondialdehyde; P | 2008 |
Ulcerative cystitis associated with phenylbutazone administration in two horses.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Cystitis; Hematuria; Horse Dise | 2011 |
Phenylbutazone and flunixin meglumine used singly or in combination in experimental lameness in horses.
Topics: Animals; Clonixin; Cross-Over Studies; Drug Therapy, Combination; Female; Foot Diseases; Heart Rate; | 2011 |
Anesthesia case of the month. EPAM.
Topics: Analgesics; Anesthesia, General; Anesthetics, General; Animals; Anti-Inflammatory Agents; Clonixin; | 2012 |
Towards safer and more effective analgesia.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Horse Diseases; Lameness, Animal; Male; Pain; Phen | 2013 |
Ultrasonographic findings in horses with right dorsal colitis: five cases (2000-2001).
Topics: Abdominal Pain; Animals; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Colitis; Col | 2003 |
Lower gastric ulcerogenic effect of suxibuzone compared to phenylbutazone when administered orally to horses.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Female; Gastric Mucosa; Horse Diseases; Horses; Ma | 2004 |
Preferential and non-selective cyclooxygenase inhibitors reduce inflammation during lipopolysaccharide-induced synovitis.
Topics: Animals; Anti-Inflammatory Agents; Cyclooxygenase Inhibitors; Dinoprostone; Enzyme-Linked Immunosorb | 2005 |
Use of force plate analysis to compare the analgesic effects of intravenous administration of phenylbutazone and flunixin meglumine in horses with navicular syndrome.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Clonixin; Foot Diseases; Horse Diseases; Horses; I | 2005 |
Septic arthritis and granulomatous synovitis caused by infection with Mycobacterium avium complex in a horse.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Infectious; Diagnosis, Differential; Gr | 2005 |
Evaluation of electroacupuncture treatment of horses with signs of chronic thoracolumbar pain.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Back Pain; Chronic Disease; Electroacupuncture; Fe | 2005 |
Chip fractures from the distal lateral trochlear ridge of the talus of a quarter horse gelding: a veterinary medicine clinical report.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthroscopy; Combined Modality Therapy; Fractures, | 2005 |
Intra-abdominal abscess and peritonitis in an Appaloosa gelding.
Topics: Abdominal Abscess; Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Gentamic | 2006 |
Actinobacillus pleuritis and peritonitis in a quarter horse mare.
Topics: Actinobacillus; Actinobacillus Infections; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, | 2006 |
Postpartum hemoperitoneum and septic peritonitis in a Thoroughbred mare.
Topics: Abdominal Cavity; Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Clonixin; | 2006 |
Left otitis media/interna and right maxillary sinusitis in a Percheron mare.
Topics: Analgesics, Non-Narcotic; Animals; Anti-Infective Agents; Dimethyl Sulfoxide; Drug Combinations; Fac | 2006 |
[Horse product].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Catheterization; Colic; Horse Diseases; Horses; Le | 2007 |
[Phenylbutazone, the black 'horse' of the NSAID family?].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carcinogens; Cost-Benefit Analysis; European Union | 2008 |
From firing to phenylbutazone in equine practice.
Topics: Animals; History, 19th Century; History, 20th Century; Horse Diseases; Horses; Influenza A virus; Or | 1982 |
Renal papillary necrosis in equines.
Topics: Animals; Clonixin; Horse Diseases; Horses; Kidney Papillary Necrosis; Nicotinic Acids; Phenylbutazon | 1984 |
Influence of phenylbutazone on eicosanoid levels in equine acute inflammatory exudate.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Cell Migration Inhibition; Dinoprostone; Exudates and Transud | 1984 |
Renal papillary necrosis in horses.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clonixin; Dehyd | 1983 |
Paste preparation of phenylbutazone.
Topics: Animals; Horse Diseases; Horses; Ointments; Phenylbutazone | 1983 |
Paste preparation of phenylbutazone.
Topics: Animals; Horse Diseases; Horses; Ointments; Phenylbutazone | 1983 |
Clinical efficacy of a revised dosage schedule of phenylbutazone in horses.
Topics: Animals; Drug Administration Schedule; Female; Horse Diseases; Horses; Male; Phenylbutazone | 1983 |
Phenylbutazone toxicosis in the foal.
Topics: Animals; Barium Sulfate; Colonic Diseases; Diarrhea; Female; Gastric Mucosa; Gastroscopy; Horse Dise | 1983 |
Renal papillary necrosis in horses after phenylbutazone and water deprivation.
Topics: Animals; Horse Diseases; Horses; Kidney; Kidney Papillary Necrosis; Phenylbutazone; Time Factors; Wa | 1983 |
Facial and vestibulocochlear nerve disease in six horses.
Topics: Ampicillin; Animals; Chloramphenicol; Cochlear Nerve; Facial Paralysis; Female; Horse Diseases; Hors | 1983 |
Renal medullary crest necrosis associated with phenylbutazone therapy in horses.
Topics: Animals; Female; Horse Diseases; Horses; Kidney Medulla; Kidney Papillary Necrosis; Male; Phenylbuta | 1983 |
Effects of toxic doses of phenylbutazone in ponies.
Topics: Administration, Oral; Animals; Gastrointestinal Diseases; Horse Diseases; Horses; Injections, Intrav | 1983 |
Paste preparation of phenylbutazone.
Topics: Animals; Dose-Response Relationship, Drug; Horse Diseases; Horses; Ointments; Phenylbutazone; Powder | 1983 |
Phenylbutazone toxicosis in the horse: a clinical study.
Topics: Administration, Oral; Animals; Body Weight; Colon; Female; Horse Diseases; Horses; Hypoproteinemia; | 1984 |
Vascular pathology in phenylbutazone intoxicated horses.
Topics: Animals; Horse Diseases; Horses; Male; Phenylbutazone; Vascular Diseases; Veins | 1984 |
Therapeutic effect of phenylbutazone on experimental acute Escherichia coli endotoxemia in ponies.
Topics: Animals; Blood Glucose; Carbon Dioxide; Endotoxins; Escherichia coli; Glucuronidase; Hematocrit; Hor | 1981 |
Effects of large doses of phenylbutazone administration to horses.
Topics: Animals; Anti-Inflammatory Agents; Cat Diseases; Cats; Dog Diseases; Dogs; Female; Gastric Mucosa; G | 1983 |
Biochemical and haematological effects of a revised dosage schedule of phenylbutazone in horses.
Topics: Animals; Drug Administration Schedule; Hematologic Tests; Horse Diseases; Horses; Ointments; Phenylb | 1983 |
Studies on a new paste preparation of phenylbutazone.
Topics: Absorption; Animals; Biological Availability; Horse Diseases; Horses; Kinetics; Ointments; Phenylbut | 1983 |
Equine ulcerative lymphangitis caused by Pasteurella hemolytica (2 case reports).
Topics: Animals; Chloramphenicol; Furosemide; Horse Diseases; Horses; Lymphangitis; Male; Pasteurella Infect | 1981 |
Two cases of Fusarium keratomycosis in the horse.
Topics: Animals; Cautery; Corneal Ulcer; Fusarium; Horse Diseases; Horses; Male; Mycoses; Natamycin; Phenylb | 1982 |
Paste formulation of phenylbutazone.
Topics: Animals; Horse Diseases; Horses; Ointments; Phenylbutazone | 1982 |
Science and the administration of phenylbutazone.
Topics: Animals; Horse Diseases; Horses; Phenylbutazone | 1981 |
Pharmacokinetics of phenylbutazone and its metabolites in the horse.
Topics: Animals; Chemical Phenomena; Chemistry; Female; Horse Diseases; Horses; Kinetics; Lameness, Animal; | 1981 |
Phenylbutazone toxicosis in equidae: a biochemical and pathophysiological study.
Topics: Animals; Blood Proteins; Blood Urea Nitrogen; Cecum; Colon; Extracellular Space; Female; Horse Disea | 1981 |
Non-steroidal anti-inflammatory agents in the horse.
Topics: Animals; Anti-Inflammatory Agents; Clonixin; Horse Diseases; Horses; Inflammation; Meclofenamic Acid | 1981 |
Phenylbutazone toxicity in ponies.
Topics: Animals; Gastrointestinal Diseases; Horse Diseases; Horses; Hypoproteinemia; Phenylbutazone; Protein | 1980 |
AVMA/Practice Group perspectives: use of drug labels in the prescription of antimicrobial therapy. Representing the American Association of Equine Practitioners (AAEP).
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Cephalosporins; Clonixin; D | 1995 |
Effects of concurrent administration of phenylbutazone and flunixin meglumine on pharmacokinetic variables and in vitro generation of thromboxane B2 in mares.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Clonixin; Drug Interactions; Female; Horse Disease | 1993 |
Comparison of adverse effects of phenylbutazone, flunixin meglumine, and ketoprofen in horses.
Topics: Animals; Anorexia; Blood Proteins; Clonixin; Female; Gastric Mucosa; Gastroscopy; Horse Diseases; Ho | 1993 |
Clostridium difficile associated with typhlocolitis in an adult horse.
Topics: Animals; Antidiarrheals; Cecal Diseases; Cecum; Clostridioides difficile; Colitis; Diarrhea; Horse D | 1993 |
Effects of ketoprofen and phenylbutazone on chronic hoof pain and lameness in the horse.
Topics: Analgesia; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Female; Foot Diseases; | 1995 |
Infection of the intertubercular bursa in horses: four cases (1978-1991).
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bursitis; Drug Therapy, Combination; Forelimb; Hor | 1996 |
Descriptive epidemiological study of equine laminitis.
Topics: Acepromazine; Acute Disease; Administration, Topical; Age Factors; Animals; Anti-Inflammatory Agents | 1995 |
Pulmonary vascular pressures of strenuously exercising thoroughbreds after administration of phenylbutazone.
Topics: Animals; Blood Pressure; Female; Heart Rate; Hemorrhage; Horse Diseases; Horses; Hypertension, Pulmo | 1996 |
The effect of drugs used in the treatment of osteoarthrosis on stromelysin (proteoglycanase) of equine synovial cell origin.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Betamethasone; Clonixin; | 1988 |
Evaluation of sodium hyaluronate therapy in induced septic arthritis in the horse.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Infectious; Cart | 1992 |
Antagonism of endotoxin-induced disruption of equine bowel motility by flunixin and phenylbutazone.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Clonixin; Colon; Dose-Response Relationship, Drug; | 1989 |
Cervical diskospondylitis in two horses.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cervical Vertebrae; Diagnosis, Differential; Horse | 1997 |
Infectious temporomandibular joint disease in the horse: computed tomographic diagnosis and treatment of two cases.
Topics: Ampicillin; Animals; Anti-Inflammatory Agents, Non-Steroidal; Clonixin; Horse Diseases; Horses; Male | 1997 |
Reconstruction of the jugular vein in horses with post thrombophlebitis stenosis using saphenous vein graft.
Topics: Ampicillin; Anastomosis, Surgical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; | 1998 |
Medical management of urinary calculi in a stallion with breeding dysfunction.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Urinary; Anti-Inflamma | 1998 |
Renal medullary rim sign in 2 adult quarter horses.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Horse Diseases; Horses; Kidney Diseases; Kidney Me | 1998 |
Partial phallectomy to treat priapism in a horse.
Topics: Anesthesia, General; Anesthetics, Inhalation; Animals; Anti-Infective Agents, Urinary; Anti-Inflamma | 1999 |
[Navicular disease in the hind limb of a Warmblood horse].
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dexamethasone; Female; Foot | 1999 |
Ulceration and stricture of the right dorsal colon after phenylbutazone administration in four horses.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colonic Diseases; Constriction, Pathologic; Fatal | 1999 |
Effects of phenylbutazone on bone activity and formation in horses.
Topics: Alkaline Phosphatase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Bone Density; Bone R | 2000 |
Laparoscopic intra-abdominal ligation of the testicular artery following castration in a horse.
Topics: Animals; Anti-Infective Agents, Urinary; Anti-Inflammatory Agents, Non-Steroidal; Arteries; Blood Tr | 2000 |
Questions duration of treatment with phenylbutazone.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone Diseases; Bone Remodeling; Horse Diseases; Ho | 2000 |
Laminar microvascular flow, measured by means of laser Doppler flowmetry, during the prodromal stages of black walnut-induced laminitis in horses.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Body Temperature; Foot Diseases; F | 2000 |
Treatment of granular cell tumor via complete right lung resection in a horse.
Topics: Analgesics, Opioid; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Broncho | 2000 |
Fistulation of the auditory tube diverticulum (guttural pouch) with a neodymium:yttrium-aluminum-garnet laser for treatment of chronic empyema in two horses.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Dexamethasone; Ear Diseases; Empy | 2001 |
Osteomyelitis of the sustentaculum tali in horses: 10 cases (1992-1998).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Debridement; Female; Follow | 2001 |
Treatment and prognosis for cunean tendon bursitis-tarsitis of Standardbred horses.
Topics: Animals; Bursitis; Horse Diseases; Horses; Methylprednisolone; Phenylbutazone; Prognosis; Tendinopat | 1979 |
Phenylbutazone toxicity in ponies.
Topics: Animals; Horse Diseases; Horses; Phenylbutazone | 1979 |
Phenylbutazone toxicity in ponies.
Topics: Administration, Oral; Animals; Horse Diseases; Horses; Injections, Intravenous; Intestines; Phenylbu | 1979 |
Navicular disease in the horse: risk factors, radiographic changes, and response to therapy.
Topics: Animals; Bursitis; Female; Foot Diseases; Forelimb; Horse Diseases; Horses; Male; Osteitis; Phenylbu | 1977 |
Arthroscopic removal of a palmar radial osteochondroma causing carpal canal syndrome in a horse.
Topics: Animals; Arthroscopy; Bone Neoplasms; Carpal Tunnel Syndrome; Carpus, Animal; Chemotherapy, Adjuvant | 1992 |
Anti-inflammatory drugs inhibit degradation of equine synovial fluid induced by free radicals.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dimethyl Sulfox | 1991 |
Poisoning with equine phenylbutazone in a racetrack worker.
Topics: Acute Kidney Injury; Adult; Animals; Chemical and Drug Induced Liver Injury; Coma; Dogs; Drug Overdo | 1991 |
Use of transendoscopic contact neodymium:yttrium aluminum garnet laser to drain dorsal epiglottic abscesses in two horses.
Topics: Abscess; Animals; Epiglottis; Female; Horse Diseases; Horses; Laryngoscopy; Laser Therapy; Male; Pen | 1991 |
Treatment of right dorsal ulcerative colitis in a horse.
Topics: Anastomosis, Surgical; Animals; Colectomy; Colitis, Ulcerative; Horse Diseases; Horses; Male; Phenyl | 1990 |
The isoelectric focusing properties of serum alkaline phosphatase in disease and following prednisolone and phenylbutazone administration in the horse.
Topics: Alkaline Phosphatase; Animals; Female; Horse Diseases; Horses; Intestinal Diseases; Isoelectric Focu | 1990 |
Copper salicylate and copper phenylbutazone as topically applied anti-inflammatory agents in the rat and horse.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Dimethyl Sul | 1990 |
The effects of phenylbutazone on the morphology and prostaglandin concentrations of the pyloric mucosa of the equine stomach.
Topics: Animals; Gastric Mucosa; Horse Diseases; Horses; Microscopy, Electron; Phenylbutazone; Prostaglandin | 1990 |
The protective effects of sucralfate and ranitidine in foals experimentally intoxicated with phenylbutazone.
Topics: Animals; Animals, Newborn; Blood Chemical Analysis; Digestive System Diseases; Duodenum; Hematologic | 1989 |
Horse pill ("bute") hemorrhage.
Topics: Adult; Animals; Gastrointestinal Hemorrhage; Horse Diseases; Horses; Humans; Male; Phenylbutazone; S | 1988 |
Septicemic salmonellosis and suspected phenylbutazone toxicosis in an aged pony.
Topics: Animals; Horse Diseases; Horses; Male; Peptic Ulcer; Phenylbutazone; Salmonella Infections, Animal; | 1988 |
Effects of a phenylbutazone paste in ponies: model of acute nonimmune inflammation.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Body Temperature; Dinoprostone; Disease Models, Animal; Exuda | 1986 |
Healing of experimentally induced corneal ulcers in horses.
Topics: Animals; Atropine; Chloramphenicol; Corneal Ulcer; Female; Horse Diseases; Horses; Male; Ointments; | 1987 |
Comparison of various treatments for experimentally induced equine infectious arthritis.
Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Arthritis, Infectious; Arthrography; Cartilage | 1987 |
Experimentally induced phenylbutazone toxicosis in ponies: description of the syndrome and its prevention with synthetic prostaglandin E2.
Topics: Animals; Dinoprostone; Female; Gastrointestinal Diseases; Horse Diseases; Horses; Intestinal Mucosa; | 1985 |
[An undesirable drug interaction in horses? Complications which can occur during the administration of coumarin derivatives and phenylbutazone].
Topics: Animals; Coumarins; Dogs; Drug Interactions; Horse Diseases; Horses; Phenylbutazone; Vitamin K | 1985 |
Suspected non-steroidal anti-inflammatory drug toxicity in a horse.
Topics: Aminopyrine; Animals; Anti-Inflammatory Agents; Butylscopolammonium Bromide; Dipyrone; Drug Combinat | 1985 |
Uses and misuses of anti-inflammatory drugs in racehorses. 1.
Topics: Adrenocorticotropic Hormone; Animals; Anti-Inflammatory Agents; Dimethyl Sulfoxide; Glucocorticoids; | 1972 |
A clinician's views on the use and misuse of phenylbutazone.
Topics: Animals; Horse Diseases; Horses; Humans; Movement Disorders; Phenylbutazone; Substance-Related Disor | 1972 |
Uses and misuses of anti-inflammatory drus in racehorses. II.
Topics: Animals; Anti-Inflammatory Agents; Dexamethasone; Horse Diseases; Horses; Humans; Movement Disorders | 1972 |
[Study of processes leading to an increase of pulmonary marginal distance in the horse].
Topics: Animals; Auscultation; Bronchitis; Horse Diseases; Horses; Injections, Intravenous; Lung; Percussion | 1973 |